Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Bevacizumab and Aflibercept in Treatment of Diabetic Macular Edema

NCT07338097 is registered in ClinicalTrials.gov with CMH Multan Institute of Medical Sciences as lead sponsor.

NCT NCT07338097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07338097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Bevacizumab and Aflibercept in Treatment of Diabetic Macular Edema
Lead sponsor
CMH Multan Institute of Medical Sciences
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
September 7, 2025
Completion date
February 7, 2026
Enrollment
116 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema (dme)